Search - tctmd.com

Displaying 621 - 640 of 1184

Sort: Relevancy | Date

Presentation TCT 2013

TCT-50. Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study

Presenter: Philippe Généreux

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

News Industry News

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

October 29, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

Presentation TCT 2013

Restenosis and Stent Thrombosis

Presenter: Kevin Croce

October 28, 2013

Presentation TCT 2013

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Presenter: John Ormiston

October 28, 2013

Presentation TCT 2013

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Presenter: Robert Byrne

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora...

Presenter: Philippe Généreux

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

News Daily News

SYNTAX: La Trombosis del Stent Influye Más en la Mortalidad que la Oclusión del Injerto

Leah Lawrence

October 25, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

Presentation

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

Presenter: V. Farooq

October 21, 2013

Advertisement

TCT-50. Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

Intraprocedural ST Predicts Adverse Short-Term Events

Restenosis and Stent Thrombosis

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora...

Cre8, BioFreedom Polymer-Free DES Show Promise

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

ABSORB III and IV Trials Aim to Prove Superiority of BVS

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

SYNTAX: La Trombosis del Stent Influye Más en la Mortalidad que la Oclusión del Injerto

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content